EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Effect of Peer Comparison Feedback and Professional Norms on Vitamin D Testing and Generic Medication Prescribing

Tobias Müller, Michael Gerfin, Raf Van Gestel

NEJM Evidence · 2026

DOI: 10.1056/evidoa2400308 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift NEJM Evidence, 2026. Verfasst von Tobias Müller und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Health Economics & Policy, Bern University of Applied Sciences, Bern, Switzerland. Hauptthemen laut MEDLINE: Vitamin D, Drugs, Generic, Practice Patterns, Physicians', Physicians, Primary Care. Die Arbeit nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Organization for Economic Cooperation and Development (OECD) estimates suggest that 20% of health care spending is wasteful or even harmful. Previous interventions have had limited success in discouraging low-value care in medical practice. METHODS: We conducted a nationwide randomized controlled trial among primary care physicians (PCPs) in Switzerland (November 2020-December 2021). We randomly assigned PCPs to one of three intervention groups related to low-value care (vitamin D testing, generic prescribing, or a cost intervention) or a control group. This article reports results for the vitamin D testing and generic prescribing interventions compared with the common control group. PCPs in the intervention groups received a personalized information letter combining professional norms and peer comparison feedback about the low-value service (either vitamin D testing or prescribing of nongeneric medications). Primary endpoints were (1) the number of vitamin D tests per 100 patients and (2) the share of generic medications prescribed. We estimated average treatment effects using linear regression and assessed effect heterogeneity with a causal forest. RESULTS: A total of 618 PCPs were randomly assigned to the vitamin D intervention, 597 to the generic prescribing intervention and 601 to the common control group. The intervention reduced average vitamin D testing by 3.66 tests per 100 patients (95% confidence interval [CI], -5.42 to -1.89; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vitamin DDrugs, GenericPractice Patterns, Physicians'Physicians, Primary CareDrug PrescriptionsHumansSwitzerlandFemaleMaleMiddle AgedFeedbackPeer Group

Substanzen

Vitamin DDrugs, Generic

Autor:innen und Institutionen

  • Institute of Health Economics & Policy, Bern University of Applied Sciences, Bern, Switzerland.
  • University of Bern, Bern, Switzerland.
  • Leuven Institute for Healthcare Policy, KU Leuven, Leuven, Belgium.

Zitieren

APA

Müller, T., Gerfin, M., & Van Gestel, R. (2026). Effect of Peer Comparison Feedback and Professional Norms on Vitamin D Testing and Generic Medication Prescribing. NEJM Evidence. https://doi.org/10.1056/evidoa2400308

Vancouver

Müller T, Gerfin M, Van Gestel R. Effect of Peer Comparison Feedback and Professional Norms on Vitamin D Testing and Generic Medication Prescribing. NEJM Evidence. 2026. doi:10.1056/evidoa2400308

BibTeX
@article{Mller2026,
  author = {Müller, Tobias and Gerfin, Michael and Van Gestel, Raf},
  title = {Effect of Peer Comparison Feedback and Professional Norms on Vitamin D Testing and Generic Medication Prescribing},
  journal = {NEJM Evidence},
  year = {2026},
  doi = {10.1056/evidoa2400308}
}
Kostenlos starten →